Navigation Links
Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper
Date:4/14/2011

line and 6 months are presented below. Although the individual p-values of the cognitive scores did not achieve statistical significance (p < 0.05), all three of these cognitive measures favored the treatment group versus the placebo group.
  • Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog), an average net improvement of 0.41 points in favor of the treatment group versus placebo (p < 0.36)
  • Clinical Dementia Rating Scale - Sum of Boxes (CDR-SOB), an average net improvement of 0.38 points in favor of the treatment group versus placebo (p < 0.10)
  • Mini Mental State Examination (MMSE), an average net improvement of 0.19 points in favor of the treatment group versus placebo (p < 0.42)

  • The Estimated Generalized Least Square method(1) was used to calculate a composite cognition score combining each of the secondary cognitive measures (ADAS-Cog, CDR-SOB and MMSE) at baseline and 6 months. The composite cognitive score approached statistical significance, indicating a strong trend toward cognitive benefit favoring the treatment group (p < 0.15).

  • Results reported from Part 2 of this clinical study demonstrated that reaZin was safe and well tolerated by subjects in the treatment group and dropouts were equivalent across the treatment and placebo groups. These results confirm the previously reported results from Part 1 of the clinical study (April 14, 2010) that demonstrated reaZin was well tolerated and superior to Galzin®, an FDA-approved zinc preparation.

A copy of the poster presented at the AAN meeting is available using the following URL: www.adeonapharma.com/AANposter.pdf.

"We are highly encouraged by the results from this clinical study, especially achieving the
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
2. New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions
3. GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
4. Visual Healthcare to Support Chinese Clinical Trials
5. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
6. Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
7. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
8. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
9. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
10. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
11. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... PINE BROOK, N.J. , Sept. 22, 2014 ... developing antibody therapies to treat infectious disease, today ... adult volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab ... of inhalational anthrax and data from these studies ... when administered intravenously (IV) at the intended therapeutic ...
(Date:9/22/2014)...  AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... machines, announced today that they are starting production of ... unit is designed for placement inside optical shops and ... statistics, there are over 20,000 optical stores in ... world,s first automated kiosk dedicated to cleaning and sanitizing ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a ... solutions for medical and surgical procedures, among other ... deal with Munich -based Brainlab ... ® Navigation. This agreement applies to the ... cross-disciplinary U.S. sales and all distribution outside the ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... Pevion Biotech AG today announced ... therapeutic Candida vaccine PEV7, demonstrating the generation of specific ... Furthermore, the results again confirm the capability of Pevion,s ... long-lasting immunity in humans against otherwise weak antigens ...
... Mass. and MIAMI, Jan. 16, 2012 Boston Scientific ... endpoint data from its ORION trial, demonstrating excellent outcomes ... patients with iliac artery disease, a form of peripheral ... insufficient blood flow.  Results were presented today by Daniel ...
Cached Medicine Technology:Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 2Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 2Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 4Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 5
(Date:9/22/2014)... Utah (PRWEB) September 23, 2014 ... and corporate training, will be attending and exhibiting ... the American Health Information Management Association (AHIMA) in ... September 27 through October 1, and Career Step ... on its suite of coding training products, including ...
(Date:9/22/2014)... (PRWEB) September 23, 2014 The Marietta ... helping to promote National Breast Cancer Awareness Month ... contribute awareness to cause, prevention, diagnosis, treatment and cure by ... offices across the U.S. , A pink edition Philips ... that can tell us why the Sonicare is important to ...
(Date:9/22/2014)... During the annual Oregon Health Care Association ... care and senior housing industry are recognized for their ... of others. , This year, Nicolette Merino, Regional ... awarded the OHCA Special Service Award. This award is ... assist OHCA in reaching strategic objectives or help achieve ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 On ... Radio Network launched their first evening show, “KC After Dark.” ... Marcus Edwards, “KC After Dark” will air every Tuesday at ... a free iPad for the 50th caller, and because of ... well past the call in mark with 500 callers. ...
(Date:9/22/2014)... Sterling Heights, MI (PRWEB) September 22, 2014 ... will be partnering with Playworks, a local nonprofit that is ... At least 50 volunteers including UHY employees, their families and ... Americas School to help paint on cement games and graphics, ... , This outing was originally scheduled to occur in ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3
... Neuroradiologist in the Mayo clinic said that after the treatment ... ,He says that the treatment is very effective when compared ... ,He also explains that vertebroplasty is a process in ... compression fractures are present. These compressions arise due to osteoporosis. ...
... worst AIDS affected countries in the world, with an infection ... all // those who were in need of it. The ... to 110,000 people. The country is badly in need of ... entire nation will be destroyed socially and economically. ...
... might be using "substandard poultry vaccine", which could be the ... flu //in that country. ,Dr Robert Webster, ... that this problem was not confined to mainland China alone. ... vaccines. I think there are substandard vaccines for influenza in ...
... woman in Gopinathpur village after she underwent a family planning ... panic and confusion in the Kendrapara district. // ... been operated (tubectomy) as a part of the health camp, ... husband, Sudarshan, Jayanti had complaints of severe abdominal pain after ...
... validated from Medicare data as Medicare covers more than 40 ... be known from these data // reports Professor Richard Platt, ... useful for knowing the true benefits of the drug and ... the data obtained from Medicare would be far better than ...
... molecular link between the type 2 diabetes onset and ... fat. // This is because of the disruption in ... according to a recent research. According to the researchers, ... glycosyltransferase (GnT-4a) disrupts insulin production. ,The experiments ...
Cached Medicine News:Health News:Improved cure and activity level seen among patients treated by Vertebroplasty. 2Health News:Botswana Continues Its Fight Against AIDS 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: